AU2001245459A1 - Retinoid formulations for aerosolization and inhalation - Google Patents

Retinoid formulations for aerosolization and inhalation

Info

Publication number
AU2001245459A1
AU2001245459A1 AU2001245459A AU4545901A AU2001245459A1 AU 2001245459 A1 AU2001245459 A1 AU 2001245459A1 AU 2001245459 A AU2001245459 A AU 2001245459A AU 4545901 A AU4545901 A AU 4545901A AU 2001245459 A1 AU2001245459 A1 AU 2001245459A1
Authority
AU
Australia
Prior art keywords
aerosolization
inhalation
formulations
retinoid formulations
retinoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001245459A
Other languages
English (en)
Inventor
Alan R. Dahl
Luigi M. De Luca
James L. Mulshine
Michael E. Placke
William C. Zimlich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Battelle Memorial Institute Inc
Original Assignee
Battelle Memorial Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Battelle Memorial Institute Inc filed Critical Battelle Memorial Institute Inc
Publication of AU2001245459A1 publication Critical patent/AU2001245459A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001245459A 2000-03-07 2001-03-07 Retinoid formulations for aerosolization and inhalation Abandoned AU2001245459A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18753900P 2000-03-07 2000-03-07
US60187539 2000-03-07
PCT/US2001/007123 WO2001066104A2 (en) 2000-03-07 2001-03-07 Retinoid formulations for aerosolization and inhalation

Publications (1)

Publication Number Publication Date
AU2001245459A1 true AU2001245459A1 (en) 2001-09-17

Family

ID=22689393

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001245459A Abandoned AU2001245459A1 (en) 2000-03-07 2001-03-07 Retinoid formulations for aerosolization and inhalation

Country Status (5)

Country Link
EP (1) EP1263420B1 (de)
AT (1) ATE303801T1 (de)
AU (1) AU2001245459A1 (de)
DE (1) DE60113240T2 (de)
WO (1) WO2001066104A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2021491A4 (de) * 2006-05-10 2010-02-24 Univ Texas Nachweis von tumorbiomarkern bei mundkrebs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003064A3 (de) * 1977-12-07 1979-08-08 Rabam Limited Verfahren zum Einführen von Vitamin A-Analogen in die Atemwege eines Zigarettenrauchers
DE3815221C2 (de) * 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US6251941B1 (en) * 1996-04-19 2001-06-26 Sloan-Kettering Institute For Cancer Research Use of inhaled retinoids in the prevention of cancer
WO2001010252A1 (en) * 1999-08-11 2001-02-15 Therapeutics 2000, Inc. Anti-oxidant inhalant and method

Also Published As

Publication number Publication date
WO2001066104A3 (en) 2002-01-24
EP1263420A2 (de) 2002-12-11
DE60113240D1 (de) 2005-10-13
EP1263420B1 (de) 2005-09-07
DE60113240T2 (de) 2006-06-29
WO2001066104A2 (en) 2001-09-13
ATE303801T1 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
WO2001076671A3 (en) Aerosol delivery apparatus with positive expiratory pressure capacity
WO2005008591A3 (en) System and method for endoscopic path planning
ATE432064T1 (de) Einführung eines aerosols in einen beatmungsgerätekreislauf
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
AP1611A (en) Systems and methods for aerosolizing pharmaceutical formulations.
AU6009098A (en) Disposable inhaler
WO2002047668A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und ciclesonide
AU2003293116A1 (en) Delivery method and device for implantable bronchial isolation devices
AU2002339093A1 (en) Inhalation of vapour of therapeutical substances, like e.g. cannabis extract
AU2002251898A1 (en) Guidewire and lock mechanism
EP3494995A3 (de) Extra feine formoterolformulierungen
BRPI0509026A (pt) formulação de aerossol, método para a prevenção e tratamento de infecção causada por bactéria do trato respiratório, e, solução
WO2004018011A3 (en) Methods for easing pain and anxiety from atrial or ventricular defibrillation
RS20090105A (en) Medicament compositions based on tiotropium salts and on salmetrol salts
DE60202477D1 (de) Vorrichtung zur verabreichung einer substanz
HK1080284A1 (en) Pharmaceutical composition for treatment of rhinitis
AU2001278131A1 (en) Generation, delivery, measurement and control of aerosol boli for diagnostics and treatments of the respiratory/pulmonary tract of a patient
AU2002316771A1 (en) Guanylate-cyclase c ligand, administered via the airways, for the treatment of respiratory airway problems
YU24403A (sh) Novi retinoidi za terapiju emfizema
AU6471500A (en) Aqueous nasal formulation
WO2005041921A3 (en) Dry powder compositions for inhalation therapy comprising calcium stearate, medical devices therefor
AU2003300435A1 (en) Tissue and organ preservation, protection and resuscitation
AU3598299A (en) Improved compositions for inhalation
AU2001245459A1 (en) Retinoid formulations for aerosolization and inhalation
WO2002069979A3 (en) Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate